Research output per year
Research output per year
Personal profile
Education/Academic qualification
Medicine, PhD, Immunotherapy for Advanced Melanoma, University of Melbourne
Award Date: 8 Dec 2021
Immunology, BSc (Hons), Murdoch University
28 Feb 2002 → 1 Dec 2002
Award Date: 15 Dec 2002
Medicine, MBBS, University of Queensland
Feb 2003 → Dec 2007
External positions
Medical Oncologist, Peter Maccallum Cancer Centre
1 Feb 2016 → 2021
Research expertise keywords
- Melanoma
- Breast cancer research
- Cancer research
- Immunotherapy
Fingerprint
Dive into the research topics where Peter Lau is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)
Lau, P. K. H., Feran, B., Smith, L., Lasocki, A., Molania, R., Smith, K., Weppler, A., Angel, C., Kee, D., Bhave, P., Lee, B., Young, R. J., Iravani, A., Yeang, H. A., Vergara, I. A., Kok, D., Drummond, K., Neeson, P. J., Sheppard, K. E. & Papenfuss, T. & 3 others, , 8 Oct 2021, In: Journal for ImmunoTherapy of Cancer . 9, 10, e002995.Research output: Contribution to journal › Article › peer-review
Open Access23 Citations (Scopus) -
Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8+ T cell immunity against melanoma
Bachem, A., Clarke, M., Kong, G., Tarasova, I., Dryburgh, L., Kosack, L., Lee, A. R., Newland, L. D., Wagner, T., Bawden, E., Yap, K. M., Wilson, M. D., Engel, S., Wilson, K. R., Russ, B. E., Tandon, K., Lau, P. K. H., McArthur, G., Marcelino, V. R. & Beavis, P. A. & 7 others, , 11 Nov 2025, In: Immunity. 58, 11, p. 2799-2813.e8Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer
Hoon, S. N., Lau, P. K. H., White, A. M., Bulsara, M. K., Banks, P. D. & Redfern, A. D., 26 May 2021, In: Cochrane Database of Systematic Reviews. 2021, 5, CD011220.Research output: Contribution to journal › Review article › peer-review
Open Access13 Citations (Scopus) -
300MO Puxitatug samrotecan (P-Sam, AZD8205) in patients (pts) with HR+/HER2– breast cancer (BC): A first-in-human phase I/IIa dose escalation and expansion study
Baird, R. D., Chung, W.-P., Schmid, P., Dongen, M. V., Jung, K. H., Naito, Y., Shimoi, T., Lau, P. K. H., Meric-Bernstam, F., Oh, D.-Y., Rubovszky, G., Van Gorp, T., Aftimos, P., Lugowska, I., Sanai, E., Dubois, V. F. S., Miller, N., Varga, A., Luheshi, N. & Kim, G. M., May 2025, In: ESMO Open. 10, S4Research output: Contribution to journal › Abstract/Meeting Abstract
Open Access -
A signal-seeking phase 2 study of tremelimumab in advanced cancers with high tumour mutational burden
Thavaneswaran, S., Lin, F., Espinoza, D., Grady, J., Kok, P.-S., Chinchen, S., Pavlakis, N., Andelkovic, V., Charakidis, M., Craft, P., Brown, M., Desai, J., Lau, P., Kansara, M., Simes, J. & Thomas, D., 2025, In: npj Precision Oncology. 9, 8 p., 372.Research output: Contribution to journal › Article › peer-review
Open Access
-
Therapeutic opportunities for metastatic breast cancer resistant to anti-hormonal therapies
Redfern, A. (Investigator 01), Golden, E. (Investigator 02), Khinsar, K. H. (Investigator 03), Wang, E. (Investigator 04), Winteringham, L. (Investigator 05), Lau, P. (Investigator 06) & Blancafort, P. (Investigator 07)
1/01/25 → 1/01/26
Project: Research
-
Establishing TIL therapy For Immunotherapy-Resistant Melanoma
Nilsson, J. (Investigator 01), Gray, E. (Investigator 02), Waithman, J. (Investigator 03) & Lau, P. (Investigator 04)
1/04/24 → 31/12/28
Project: Research
-
Hck in tumour associated macrophages: a novel drug target and a diagnostic tool for invasive triple negative breast cancer
Pixley, F. (Investigator 01), Ernst, M. (Investigator 02), Poh, A. (Investigator 03), Lau, P. (Investigator 04) & Dabner, M. (Investigator 05)
1/01/23 → 31/12/24
Project: Research
-
Novel insights into immune control of dormant tumours.
McDonnell, A. (Investigator 01), Lau, P. (Investigator 02), McCoy, M. (Investigator 03) & Armitage, J. (Investigator 04)
4/01/21 → 30/12/23
Project: Research